Kalous Kelsey S, Wynia-Smith Sarah L, Olp Michael D, Smith Brian C
From the Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226.
From the Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226
J Biol Chem. 2016 Dec 2;291(49):25398-25410. doi: 10.1074/jbc.M116.754655. Epub 2016 Oct 18.
The sirtuin family of proteins catalyze the NAD-dependent deacylation of acyl-lysine residues. Humans encode seven sirtuins (Sirt1-7), and recent studies have suggested that post-translational modification of Sirt1 by cysteine S-nitrosation correlates with increased acetylation of Sirt1 deacetylase substrates. However, the mechanism of Sirt1 inhibition by S-nitrosation was unknown. Here, we show that Sirt1 is transnitrosated and inhibited by the physiologically relevant nitrosothiol S-nitrosoglutathione. Steady-state kinetic analyses and binding assays were consistent with Sirt1 S-nitrosation inhibiting binding of both the NAD and acetyl-lysine substrates. Sirt1 S-nitrosation correlated with Zn release from the conserved sirtuin Zn-tetrathiolate and a loss of α-helical structure without overall thermal destabilization of the enzyme. Molecular dynamics simulations suggested that Zn loss due to Sirt1 S-nitrosation results in repositioning of the tetrathiolate subdomain away from the rest of the catalytic domain, thereby disrupting the NAD and acetyl-lysine-binding sites. Sirt1 S-nitrosation was reversed upon exposure to the thiol-based reducing agents, including physiologically relevant concentrations of the cellular reducing agent glutathione. Reversal of S-nitrosation resulted in full restoration of Sirt1 activity only in the presence of Zn, consistent with S-nitrosation of the Zn-tetrathiolate as the primary source of Sirt1 inhibition upon S-nitrosoglutathione treatment.
沉默调节蛋白家族的蛋白质催化酰基赖氨酸残基的NAD依赖性脱酰基反应。人类编码七种沉默调节蛋白(Sirt1 - 7),最近的研究表明,半胱氨酸S - 亚硝基化对Sirt1的翻译后修饰与Sirt1脱乙酰酶底物乙酰化增加相关。然而,S - 亚硝基化抑制Sirt1的机制尚不清楚。在此,我们表明Sirt1被生理相关的亚硝基硫醇S - 亚硝基谷胱甘肽转亚硝基化并受到抑制。稳态动力学分析和结合试验表明,Sirt1的S - 亚硝基化抑制了NAD和乙酰赖氨酸底物的结合。Sirt1的S - 亚硝基化与保守的沉默调节蛋白四硫醇锌配合物中的锌释放以及α - 螺旋结构的丧失相关,但酶的整体热稳定性未受影响。分子动力学模拟表明,Sirt1的S - 亚硝基化导致的锌损失会使四硫醇亚结构域从催化结构域的其余部分重新定位,从而破坏NAD和乙酰赖氨酸结合位点。暴露于基于硫醇的还原剂,包括生理相关浓度的细胞还原剂谷胱甘肽后,Sirt1的S - 亚硝基化被逆转。只有在锌存在的情况下,S - 亚硝基化的逆转才会导致Sirt1活性完全恢复,这与四硫醇锌配合物的S - 亚硝基化是S - 亚硝基谷胱甘肽处理后Sirt1抑制的主要来源一致。